NEOGENOMICS INC — Director's Dealing 2020

Aug 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2020-08-11

Reporting Person: VAN OORT DOUGLAS M (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-11	Common Stock	G	10000	—	Disposed	2277790	Direct
2020-08-11	Common Stock	G	5000	—	Disposed	2272790	Direct
2020-08-11	Common Stock	G	5000	—	Acquired	15000	Indirect
2020-08-12	Common Stock	G	10000	—	Disposed	2262790	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.52	2022-04-28	Common Stock (500000.0)	500000	Direct
Stock Option (Right to Buy)	$8.03	2023-02-26	Common Stock (500000.0)	500000	Direct
Stock Option (Right to Buy)	$19.6	2024-03-01	Common Stock (231567.0)	231567	Direct
Stock Option (Right to Buy)	$28.33	2027-03-02	Common Stock (225084.0)	225084	Direct

Footnotes

F1: Mr. VanOort transferred these shares as a bona fide gift pursuant to a transaction exempt from Section 16(b) under Rule 16b-5.

F2: Bona fide gift to an account held by Mr. VanOort's child for which Mr. VanOort is the custodian.

F3: On April 28, 2017, Mr. VanOort was granted 500,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.

F4: On February 26, 2018, Mr. VanOort was granted 500,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F5: On March 1, 2019, Mr. VanOort was granted 231,567 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F6: On March 2, 2020, Mr. VanOort was granted 225,084 stock options. These options vest ratably over the first four anniversary dates of the grant date.